RxSight, Inc. (NASDAQ:RXST) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Rxsight Inc. (RXST)
Market is closed
Sector: Ophthalmic Goods
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 3,694,825 | $222,317,620 | +8% | 2.94% |
| 2. | Driehaus Capital Richard Driehaus | 706,162 | $42,489,768 | +75% | 0.41% |
| 3. | Atika Capital Brad Farber | 402,600 | $24,224,442 | -3% | 2.37% |
| 4. | No Street Capital Jeff Osher | 350,000 | $21,059,500 | -7% | 1.29% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 326,000 | $19,615,420 | -11% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $61.09 | 5,000 | 34,840 | 2024-05-17 | Filing | ||
| $51.29 | 4,000 | 29,840 | 2024-02-14 | Filing | ||
| $50.38 | 4,000 | 25,840 | 2024-02-12 | Filing | ||
| $12.50 | 480,000 | Director | 980,000 | 2023-02-10 | Filing | |
| $12.49 | 8,150 | Director | 14,009 | 2021-11-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.45 | 278 | 30,443 | 2024-10-01 | Filing | ||
| $48.69 | 9,521 | 30,721 | 2024-10-01 | Filing | ||
| $47.96 | 5,201 | 40,242 | 2024-10-01 | Filing | ||
| $49.38 | 1,448 | 42,246 | 2024-09-30 | Filing | ||
| $48.69 | 1,652 | 43,694 | 2024-09-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,395,672 | $96,593,495 | 0.14% | |
| 2. | 2,076,470 | $83,723,269 | 0% | |
| 3. | 1,484,010 | $59,835,282 | 0% | |
| 4. | 1,186,477 | $47,838,753 | 0% | |
| 5. | 1,073,062 | $43,265,884 | 0% |
News See All
RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript
RxSight, Inc. misses on earnings expectations. Reported EPS is $-0.24699 EPS, expectations were $-0.17.
RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript
RxSight, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.36.
RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the RxSight Third Quarter 2023 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Second Quarter 2023 Earnings Conference Call. [Operator Instructions].
RxSight, Inc. (NASDAQ:RXST) Q1 2023 Earnings Call Transcript
Operator: Welcome to the RxSight First Quarter 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
RxSight, Inc. (NASDAQ:RXST) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
RxSight, Inc. (NASDAQ:RXST) Q3 2022 Earnings Call Transcript
Operator: Hello and thank you for standing by. Welcome to the RxSight Third Quarter 2022 Earnings Conference Call. At this time, all the participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Jim Chanos, Dan Sundheim, Anthony Scaramucci, Nelson Peltz, Odey Asset Management, Pool Corporation (POOL), Rxsight Inc (RXST), and More
Jim Chanos blasted meme-stock traders as immature and petulant in a tweet this week.
Billionaire Hedge Funds
